The B7 family of immune-regulatory ligands

The B7 family consists of structurally related, cell-surface protein ligands, which bind to the CD28 family of receptors on lymphocytes and regulate immune responses via 'costimulatory' or 'coinhibitory' signals.

[1]  C. Dong,et al.  B7S1, a novel B7 family member that negatively regulates T cell activation. , 2003, Immunity.

[2]  G. Zhu,et al.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.

[3]  S. Davis,et al.  LICOS, a primordial costimulatory ligand? , 2000, Current Biology.

[4]  J. Kieleczawa,et al.  Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. , 2003, Genomics.

[5]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[6]  Ciriana Orabona,et al.  CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 , 2004, Nature Immunology.

[7]  J. Egen,et al.  B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. , 2004, Immunity.

[8]  Lassila,et al.  Costimulatory Function of CD28 in Avian γδ T Cells is Evolutionarily Conserved , 1998, Scandinavian journal of immunology.

[9]  R. Mitchell,et al.  B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. , 2001, The Journal of clinical investigation.

[10]  E. Clark,et al.  Characterization of Human Inducible Costimulator Ligand Expression and Function1 , 2000, The Journal of Immunology.

[11]  D. Stuart,et al.  Crystal structure of a soluble CD28-Fab complex , 2005, Nature Immunology.

[12]  D I Stuart,et al.  Structure and dimerization of a soluble form of B7-1. , 2000, Immunity.

[13]  Yan Zhang,et al.  Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses , 2001, Nature.

[14]  Lieping Chen.  Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity , 2004, Nature Reviews Immunology.

[15]  C. Disteche,et al.  Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5. , 1994, Journal of immunology.

[16]  Michael Cammer,et al.  Structural and functional analysis of the costimulatory receptor programmed death-1. , 2004, Immunity.

[17]  U. Grohmann,et al.  CTLA-4–Ig regulates tryptophan catabolism in vivo , 2002, Nature Immunology.

[18]  C. Dong,et al.  Murine B7-H3 Is a Negative Regulator of T Cells1 , 2004, The Journal of Immunology.

[19]  Paul W. Wu,et al.  Differential Expression of Inducible Costimulator-Ligand Splice Variants: Lymphoid Regulation of Mouse GL50-B and Human GL50 Molecules , 2001, The Journal of Immunology.

[20]  A. Barclay.  Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules. , 2003, Seminars in immunology.

[21]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[22]  S. Almo,et al.  Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. F. Williams,et al.  The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.

[24]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[25]  Michael P. Cummings,et al.  MEGA (Molecular Evolutionary Genetics Analysis) , 2004 .

[26]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[27]  G. Freeman,et al.  Differential expression of alternate mB7-2 transcripts. , 1995, Journal of immunology.

[28]  M. Jordana,et al.  The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses , 2003, Nature Immunology.

[29]  Thomas A. Davis,et al.  Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[31]  Y. Wu,et al.  Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain , 1995, The Journal of experimental medicine.

[32]  G. Zhu,et al.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. , 2001, Nature immunology.

[33]  A. Rudensky,et al.  Characterization of Mouse and Human B7-H3 Genes1 , 2002, The Journal of Immunology.

[34]  P Bork,et al.  The immunoglobulin fold. Structural classification, sequence patterns and common core. , 1994, Journal of molecular biology.

[35]  P. Anton van der Merwe,et al.  The nature of molecular recognition by T cells , 2003, Nature Immunology.

[36]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[37]  Andrea Iaboni,et al.  The interaction properties of costimulatory molecules revisited. , 2002, Immunity.

[38]  A. Sharpe,et al.  B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) , 1999, The Journal of experimental medicine.

[39]  E. Simpson,et al.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.

[40]  D. Pardoll,et al.  B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells , 2001, The Journal of experimental medicine.

[41]  Mary Collins,et al.  The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. , 2002, Annual review of immunology.

[42]  G. Zhu,et al.  B7-H3: A costimulatory molecule for T cell activation and IFN-γ production , 2001, Nature Immunology.

[43]  Xian-hui He,et al.  Cloning and identification of two novel splice variants of human PD-L2. , 2004, Acta biochimica et biophysica Sinica.

[44]  M. Dougados,et al.  Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. , 2003, The New England journal of medicine.

[45]  S. Almo,et al.  Structural mechanisms of costimulation , 2002, Nature Immunology.

[46]  A. Fedorov,et al.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.

[47]  Drew M Pardoll,et al.  Differential binding properties of B7-H1 and B7-DC to programmed death-1. , 2003, Biochemical and biophysical research communications.